The fierce national debate over health care reform includes deep divisions over the appropriate roles of the federal and state governments. For example, while Sen Bernie Sanders (I-VT) calls for expanding the federal Medicare program to cover all Americans, the Trump administration pushes for the states to have far greater authority.
Read More

SUNY College of Optometry will take part in a multi-center US clinical trial sponsored by Eyenovia, Inc. to evaluate the safety and effectiveness of an investigational drug, MicroPine, to help slow myopic progression in children 3 to 12 years old.
Read More

American culture values the freedom to change and reinvent one’s self. A new study, however, reveals that Americans who do change tend to report a lower sense of well-being.
Read More

A new study published in the journal JAMA in March 2020 shows how prescription drug prices are rising faster than the rate of inflation. The decade-long trend reflects a threefold higher rise in brand-name drug prices compared to inflation if all drugs are lumped together.
Read More

Many people with chronic health conditions search social media, including YouTube videos, to learn more about how to manage their diagnoses. But these videos differ in how well they communicate information and hold viewers’ attention.
Read More

Breathing propels everything we do–so its rhythm must be carefully organized by our brain cells, right?
Read More

One of the hallmarks of cancer is cell immortality. A Northwestern University organic chemist and his team now have developed a promising molecular tool that targets and inhibits one of cell immortality’s underlying gears: the enzyme telomerase.
Read More

Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.
Read More

A small molecule that inhibits energy production in immune T-cells allows some tumors to escape treatment with an immunotherapy called PD-1 blockade therapy, says a study in mice published today in eLife.
Read More

A large study published in the journal JAMA in March 2020 reports that large pharmaceutical companies make a much larger profit from their products than other large public companies. This is important because it indicates the potential to reduce drug prices while sustaining competitive and innovative drug development and marketing.
Read More